Ingen’s products fill key void for Mountainside Medical Equipment

Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative proprietary solutions for the $8 billion respiratory market, today announced that its products have filled a key void for Mountainside Medical Equipment (www.mountainside-medical.com), a veteran-owned worldwide distributor of medical supplies based in Upstate New York.

"For decades, our customers have requested a product allowing for simpler, more accurate monitoring of oxygen as provided by their concentrator or tank," said Marty Zarnock, Jr., Vice President of Mountainside Medical Equipment. "The Smart Nasal Cannula with Oxyview is now available to meet those demands, as nursing homes, hospital residents and at-home patients can now confidently receive oxygen safety and accurately as prescribed by their medical provider with these two products."

"The Ingen Fingertip Pulse Oximeter has also proven to be an asset in respiratory monitoring at Mountainside. With its large and bright LCD display, and colorful compact design, our customers' satisfaction and sales have improved tremendously. This product addition allows us to offer our customers a high-quality, state-of-the-art oximetry product at competitive pricing. The Mountainside team looks forward to further promotion of these products and the introduction of new products with similar success," he added.

Ingen's Smart Nasal Cannula uses the Oxyview Technology that is patented and proprietary. It monitors the actual flow of oxygen nearest the patient. The product has proven to reduce service calls while at the same time provides safety and assurance directly to the patient. The company projects to increase its sales over the next 12 months while targeting export sales to China, Canada, Australia and Europe.

With approximately 23 million patients in the U.S., and an estimated 600 million patients worldwide, who suffer from chronic obstructive pulmonary disease (COPD), Ingen stands to capture $200 million in revenues over the next five years. Since an average COPD patient uses two to three nasal cannulas each month to prevent bacteria build-up within the device, there is a growing and recurring demand for the product that benefits Ingen's top and bottom line results.

"After reporting a successful quarter earlier this month, we have been focused on rapidly expanding our sales efforts and attracting high quality distributors like Mountainside Medical Equipment," said Ingen CEO Scott Sand. "We are pleased to be working with one of the top medical supply companies on Google throughout the United States and Canada and we look forward to similar agreements going forward."